Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
nanoSFERIC Nipah vaccine
- Development stage
- Preclinical
- Lead developer
- Sferogen
- Modality
- Nanoparticles → Drug Delivery Systems, Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The nanoSFERIC Nipah vaccine is a preclinical-stage vaccine candidate developed by Sferogen for the prevention of Nipah virus infection. It utilizes the company's proprietary nanoSFERIC platform, which consists of self-assembling protein nanoparticles designed to present viral antigens to the immune system. The vaccine is developed using a One-Health approach, intended for use in both humans and animals (such as pigs, which are known hosts) to interrupt transmission and provide protection against the virus. As there are currently no approved vaccines or treatments for Nipah virus, this candidate addresses a significant unmet medical need in global health security.
- Other names
- nanoSFERIC Nipah vaccine
02
Targets
NiV-G (Nipah virus attachment glycoprotein)NiV-F (Nipah virus fusion glycoprotein)BCR (Immunoglobulin G B Cell Receptor)
Beyond the preview
Go deeper on nanoSFERIC Nipah vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on nanoSFERIC Nipah vaccine.